Drug name - Alimta

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7772209

(Pediatric)

LILLY Antifolate combination therapies
May, 2022

(6 months ago)

Drugs and Companies using PEMETREXED DISODIUM ingredient

Market Authorisation Date: 04 February, 2004

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
EQ 100MG BASE/VIAL POWDER;INTRAVENOUS Prescription
EQ 500MG BASE/VIAL POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in